Immedica has developed a well-tailored and efficient approach for the successful management of rare disease products, including orphan drugs. In optimizing access to the products, we offer a package of complete commercial pharmaceutical services and strategies including marketing and sales via an experienced rare disease field force, navigation of the complex pricing and reimbursement environment, tender management, regulatory and medical affairs, drug safety and quality assurance. Immedica also runs an effective logistics chain for distribution of products, all over Europe and the Middle East. We have long-established relations and networks with key opinion leaders and other stakeholders across the rare disease areas.

Immedica always puts the patients first, and in a partnership, assets get full commitment and support in order for us to bring the valuable medicines to patients. Our principal philosophy is that everything we do should add value for our customers, partners and most importantly the patients. Immedica’s senior leadership has a long and proven track record of operating in mutually fruitful commercial partnerships, and our company possesses extensive experience from, and flexibility on, different partnership structures. Immedica is continuously searching for new products which could support in fulfilling unmet medical needs in Europe and the Middle East.